Davenport & CO LLC Pfizer Inc Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Pfizer Inc stock. As of the latest transaction made, Davenport & CO LLC holds 360,611 shares of PFE stock, worth $9.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

360,611

Previous 356,038 1.28%

Holding current value

$9.6 Million

Previous $9.96 Million 4.77%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $126,672 - $143,546	4,573 Added 1.28%	360,611 $10.4 Million
Q2 2024 Aug 06, 2024	SELL	$25.26 - $29.6 $617,505 - $723,601	-24,446 Reduced 6.42%	356,038 $9.96 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $915,082 - $1.05 Million	35,345 Added 10.24%	380,484 $10.6 Million
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $1.17 Million - $1.51 Million	-44,593 Reduced 11.44%	345,139 $9.94 Million
Q3 2023 Oct 17, 2023	SELL	$32.09 - $37.51 $214,553 - $250,791	-6,686 Reduced 1.69%	389,732 $12.9 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $130,862 - $151,405	3,623 Added 0.92%	396,418 $14.5 Million
Q1 2023 Apr 27, 2023	SELL	$39.39 - $51.28 $34,741 - $45,228	-882 Reduced 0.22%	392,795 $16 Million
Q4 2022 Jan 20, 2023	BUY	$41.75 - $54.5 $191,757 - $250,318	4,593 Added 1.18%	393,677 $0
Q3 2022 Oct 11, 2022	BUY	$43.76 - $53.42 $17,897 - $21,848	409 Added 0.11%	389,084 $17 Million
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $1.31 Million - $1.56 Million	-28,193 Reduced 6.76%	388,675 $20.4 Million
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $976,259 - $1.21 Million	21,339 Added 5.4%	416,868 $21.6 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $865,282 - $1.28 Million	-20,941 Reduced 5.03%	395,529 $23.4 Million
Q3 2021 Oct 14, 2021	SELL	$39.25 - $50.42 $1.75 Million - $2.24 Million	-44,507 Reduced 9.65%	416,470 $17.9 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $2.95 Million - $3.34 Million	82,048 Added 21.65%	460,977 $18.1 Million
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $403,487 - $455,052	-12,048 Reduced 3.08%	378,929 $13.7 Million
Q4 2020 Jan 13, 2021	BUY	$33.47 - $42.56 $253,535 - $322,392	7,575 Added 1.98%	390,977 $14.4 Million
Q3 2020 Oct 15, 2020	BUY	$31.75 - $37.25 $694,975 - $815,365	21,889 Added 6.05%	383,402 $14.1 Million
Q2 2020 Jul 28, 2020	BUY	$30.12 - $36.54 $911,069 - $1.11 Million	30,248 Added 9.13%	361,513 $11.8 Million
Q1 2020 May 05, 2020	BUY	$27.03 - $38.62 $88,577 - $126,557	3,277 Added 1.0%	331,265 $10.8 Million
Q4 2019 Jan 22, 2020	BUY	$32.92 - $37.36 $1.06 Million - $1.2 Million	32,096 Added 10.85%	327,988 $12.9 Million
Q3 2019 Oct 16, 2019	BUY	$32.49 - $42.13 $29,241 - $37,917	900 Added 0.31%	295,892 $12.8 Million
Q2 2019 Jul 10, 2019	SELL	$36.98 - $41.52 $225,430 - $253,105	-6,096 Reduced 2.02%	294,992 $12.8 Million
Q1 2019 Apr 17, 2019	BUY	$37.5 - $41.2 $209,062 - $229,690	5,575 Added 1.89%	301,088 $12.8 Million
Q4 2018 Jan 28, 2019	BUY	$38.47 - $43.86 $136,760 - $155,922	3,555 Added 1.22%	295,513 $12.9 Million
Q3 2018 Oct 11, 2018	BUY	$34.47 - $41.81 $887,257 - $1.08 Million	25,740 Added 9.67%	291,958 $12.9 Million
Q2 2018 Jul 09, 2018	BUY	$32.98 - $35.16 $439,854 - $468,928	13,337 Added 5.27%	266,218 $9.66 Million
Q1 2018 Apr 04, 2018	SELL	$31.91 - $37.02 $87,178 - $101,138	-2,732 Reduced 1.07%	252,881 $8.97 Billion
Q4 2017 Jan 17, 2018	SELL	$33.26 - $35.29 $126,853 - $134,596	-3,814 Reduced 1.47%	255,613 $9.26 Billion
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $8.04 Million - $8.86 Million	259,427	259,427 $9.26 Billion

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account